1. 103PHGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of cases of prior regorafenib. (25th November 2018) Authors: Tsuji, Y; Yuki, S; Sawada, K; Muranaka, T; Kobayashi, Y; Okuda, H; Ogawa, K; Minami, S; Honda, T; Dazai, M; Kato, T; Sasaki, T; Shindo, Y; Ota, S; Sato, A; Ueda, A; Saitoh, S; Nagai, H; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 110PHGCSG1401: A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer: Analysis of risk factors for liver dysfunction. (25th November 2018) Authors: Ishiguro, A; Yuki, S; Nakano, S; Kawamoto, Y; Sawada, K; Tsuji, Y; Honda, T; Miyagishima, T; Yoshida, S; Hatanaka, K; Sasaki, T; Muto, O; Ohnuma, H; Kato, S; Sato, A; Abe, M; Kato, K; Amano, T; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1222 Diagnosis of 1, 561 compensated cases for overwork-related cerebrovascular/cardiovascular diseases (ccvds) known as 'karoshi' in japan, 2010–2014. (24th April 2018) Authors: Yoshikawa, T; Sasaki, T; Matsumoto, S; Yamauchi, T; Kayashima, K; Kubo, T; Umezaki, S; Takahashi, M Journal: Occupational and environmental medicine Issue: Volume 75(2018)Supplement 2 Page Start: A122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1436PRandomized phase II study comparing cisplatin + pemetrexed + bevacizumab with carboplatin + paclitaxel + bevacizumab in treatment-naïve advanced non-squamous non-small cell lung cancer (CLEAR study). (23rd October 2018) Authors: Koyama, R; Udagawa, H; Sugiyama, E; Komuta, K; Mori, M; Yokoyama, T; Sasaki, T; Saito, H; Ishida, H; Nakagawa, H; Sekine, A; Tamura, A; Shingyoji, M; Mizuno, K; Nakamura, A; Kinoshita, A; Yamanaka, T; Goto, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 164PMulti-centered phase II trial of weekly 5-FU plus l-LV regimen as salvage line chemotherapy for oral fluorouracil resistant advanced gastric cancer (HGCSG1502). (24th November 2019) Authors: Sasaki, Y; Muranaka, T; Kawamoto, Y; Sawada, K; Nakatsumi, H; Harada, K; Miyagishima, T; Hatanaka, K; Dazai, M; Ueda, A; Sasaki, T; Shinada, K; Tsuji, Y; Yuki, S; Sakamoto, N; Nishimoto, N; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 166PThe comparison between UGT1A1 single heterozygous and wild type regarding the clinical outcomes of fixed dose irinotecan monotherapy for advanced gastric cancer: Multicenter retrospective study. (24th November 2019) Authors: Sasaki, T; Nakano, S; Yuki, S; Sawada, K; Muranaka, T; Kawamoto, Y; Nakatsumi, H; Ando, T; Yoshita, H; Harada, K; Kobayashi, Y; Miyagishima, T; Hatanaka, K; Tanimoto, A; Ishiguro, A; Honda, T; Dazai, M; Komatsu, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 168PA retrospective multicenter study evaluating the efficacy and safety of irinotecan in patients with advanced gastric cancer: Analysis of Glasgow Prognostic Score (GPS). (24th November 2019) Authors: Honda, T; Nakano, S; Yuki, S; Sawada, K; Muranaka, T; Kawamoto, Y; Nakatsumi, H; Yoshita, H; Ando, T; Harada, K; Kobayashi, Y; Miyagishima, T; Hatanaka, K; Tanimoto, A; Ishiguro, A; Dazai, M; Sasaki, T; Komatsu, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 195PHGCSG1601: A retrospective cohort study of the efficacy and safety of nab-paclitaxel plus gemcitabine (nab-P+GEM) for unresectable locally advanced pancreatic cancer (LAPC). (24th November 2019) Authors: Tanimoto, A; Yagisawa, M; Nakano, S; Kawamoto, Y; Yuki, S; Ishiguro, A; Takahata, T; Sato, A; Iwanaga, I; Ehira, N; Uebayashi, M; Muto, O; Sasaki, T; Hatanaka, K; Tateyama, M; Wakabayashi, T; Dazai, M; Minami, S; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 452TiPA feasibility study of edoxaban for the cancer-associated asymptomatic venous thromboembolism in Japanese gastrointestinal cancer patients receiving chemotherapy (ExCAVE study). (25th November 2018) Authors: Nakamura, M; Yagisawa, M; Saiki, T; Ishiguro, A; Sawada, K; Yuki, S; Sasaki, T; Ando, T; Ohori, H; Kotaka, M; Muto, O; Shindo, Y; Nakashima, K; Hosokawa, A; Doi, A; Izawa, N; Sunakawa, Y; Satoh, A; Ono, K; Komatsu, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 464OInduction gefitinib followed by standard chemoradiotherapy in locally advanced (LA) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations: The LOGIK0902/OLCSG0905 intergroup phase II study. (24th November 2019) Authors: Saeki, S; Hotta, K; Yamaguchi, M; Harada, D; Bessho, A; Tanaka, K; Inoue, K; Gemba, K; Inoue, K; Ichihara, E; Kishimoto, J; Sasaki, T; Shioyama, Y; Katsui, K; Sasaki, J; Kiura, K; Sugio, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗